Vitamin B1 (Thiamine): Benefits, Benfotiamine vs Sulbutiamine, Dosage

What is thiamine?

Thiamine (vitamin B₁) is a water-soluble vitamin built from a pyrimidine ring linked by a methylene bridge to a thiazole ring. After absorption it is rapidly phosphorylated to the bioactive coenzyme thiamine pyrophosphate (TPP) — also called thiamine diphosphate (TDP).

TPP is essential for four enzyme systems that connect the major fuel pathways:

• Pyruvate dehydrogenase — pyruvate → acetyl-CoA, the entry point of carbohydrates into the TCA cycle
• α-Ketoglutarate dehydrogenase — a regulated step inside the TCA cycle
• Transketolase — the rate-limiting enzyme of the non-oxidative pentose phosphate pathway, which produces ribose-5-phosphate (for nucleotides) and NADPH (for redox defense)
• Branched-chain α-keto acid dehydrogenase — leucine, isoleucine, and valine catabolism

Because every one of these reactions sits in glucose, amino acid, or nucleotide metabolism, even mild thiamine deficiency hits high-flux tissues — heart, peripheral nerves, brain — first. According to the NIH Office of Dietary Supplements, the body stores only ~30 mg of thiamine total, with a half-life of 9–18 days, which is why deficiency can develop within weeks of inadequate intake.

Evidence-based benefits of thiamine supplementation

1. Deficiency repletion (beriberi, Wernicke-Korsakoff)

The non-negotiable indication. In suspected Wernicke encephalopathy or wet/dry beriberi, parenteral (IV or IM) thiamine — typically 500 mg IV three times daily for 2–3 days, then tapered — is the standard of care, given before any glucose-containing fluid. Oral thiamine 100 mg/day is then used for ongoing repletion. This is the strongest, most clearly established use of thiamine.

2. Diabetic peripheral neuropathy (benfotiamine)

Benfotiamine 300–600 mg/day has improved nerve conduction velocity, vibration perception, and pain scores in patients with diabetic peripheral neuropathy in the BENDIP trial and a handful of similar randomized studies. Effect sizes are modest and trials are short, but benfotiamine is well tolerated and is one of the more reasonable adjunctive options for symptomatic neuropathy.

3. Diabetic complications more broadly

Plasma thiamine is often low in type 2 diabetes — partly from increased renal clearance. Mechanistically, benfotiamine activates transketolase, which diverts excess fructose-6-phosphate and glyceraldehyde-3-phosphate away from the four hyperglycemia-driven damage pathways described in Brownlee's unifying hypothesis: the polyol pathway, advanced glycation end-product (AGE) formation, the hexosamine pathway, and PKC activation. Whether this translates to lower long-term complications in humans is not yet proven.

4. Cognitive and mood effects (sulbutiamine)

Sulbutiamine is a lipid-soluble dimer of thiamine that crosses the blood–brain barrier. It is prescribed in France (Arcalion®) for asthenia and used off-label elsewhere for chronic fatigue, mild cognitive complaints, and erectile-related fatigue. Small RCTs suggest a short-term effect on subjective fatigue, but the literature is dominated by open-label French studies of variable quality. It is not first-line for any condition.

Symptoms and syndromes of thiamine deficiency

Frank thiamine deficiency presents in four overlapping clinical pictures:

• Wet beriberi — high-output heart failure, dyspnea, peripheral edema, lactic acidosis. Cardiovascular dominant.
• Dry beriberi — symmetric peripheral neuropathy, distal muscle wasting, areflexia. Neurologic dominant.
• Wernicke encephalopathy — the classic triad of confusion, ataxia, and ophthalmoplegia (often nystagmus or lateral-rectus palsy). A medical emergency: untreated, it progresses to Korsakoff in days.
• Korsakoff psychosis — irreversible anterograde amnesia and confabulation, typically following inadequately treated Wernicke.

Risk groups who genuinely need supplementation or screening:

• Alcohol use disorder (the single biggest risk group — impaired absorption plus high metabolic demand plus poor intake)
• Hyperemesis gravidarum and severe vomiting / eating disorders
• Refeeding after prolonged malnutrition (refeeding syndrome unmasks deficiency)
• Post-bariatric surgery (sleeve, Roux-en-Y, duodenal switch)
• Patients on IV-only nutrition or carbohydrate-only IV fluids without thiamine
• Chronic loop or high-dose thiazide diuretic use (urinary thiamine loss)
• Maintenance hemodialysis (dialysate clearance)

For an in-depth check, see our Wernicke encephalopathy guide.

The 5 supplement forms of thiamine, compared

The form on the label changes how much TPP your tissues actually see — and which use case it fits.

For a side-by-side, see Benfotiamine for Diabetic Neuropathy.

How much thiamine should you take?

The Recommended Dietary Allowance (RDA) for adults:

• Men 19+: 1.2 mg/day
• Women 19+: 1.1 mg/day
• Pregnancy and lactation: 1.4 mg/day

Practical dosing in supplements:

• General supplementation / B-complex: 25–100 mg/day thiamine HCl or mononitrate
• Wernicke prophylaxis (high-risk outpatients, e.g., alcohol use disorder): 100 mg/day oral or IV, often with parenteral loading first
• Diabetic peripheral neuropathy (benfotiamine): 300–600 mg/day, often split BID
• Sulbutiamine for asthenia: 200–600 mg/day, taken in the morning (it is mildly activating)

Tolerable Upper Intake Level (UL): none established. Excess water-soluble thiamine is excreted in the urine — toxicity from oral dosing is essentially unheard of.

Side effects and safety

Oral thiamine in any form is one of the safer supplements on the shelf:

• Thiamine HCl / mononitrate: rare GI upset at very high doses; well tolerated otherwise.
• Benfotiamine: consistently well tolerated in trials at 300–600 mg/day. Occasional mild GI symptoms.
• Sulbutiamine: occasional headache, irritability, and mild GI upset have been reported. Some users describe a stimulant-like effect at higher doses — dose in the morning.
• High-dose IV thiamine: rare anaphylaxis and hypersensitivity have been documented. This is the reason hospitals administer it slowly and have resuscitation available — not a concern with oral supplementation.

Drug interactions to know about

• Loop and thiazide diuretics (furosemide, bumetanide, hydrochlorothiazide) — increase urinary thiamine loss. Long-term users, especially heart-failure patients, often run low.
• Metformin — modest reductions in thiamine status have been reported; clinical significance is debated.
• Chronic alcohol — reduces intestinal thiamine absorption, increases metabolic demand, and is typically combined with poor dietary intake. The dominant cause of deficiency in developed countries.
• IV dextrose without thiamine — in a thiamine-deplete patient, this can precipitate Wernicke encephalopathy. Hospital protocols give thiamine first.
• Broad-spectrum antibiotics — modestly reduce gut bacterial thiamine synthesis, but gut synthesis is a minor source for humans, so the effect is small.

Check our free interaction checker for a complete list.

Frequently asked questions

Related articles